ArticleLab on a chip2026
Centrifuge-free separation of plasma from milliliters of whole blood for point-of-care diagnostics.
Article in Lab on a chip, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Performing efficient plasma separation from whole blood, a vital sample matrix for diagnostics, in point-of-care settings remains challenging, particularly for sensitive assays that require larger volumes than can be obtained from a finger prick. Centrifugation, the gold standard for plasma separation, relies on bulky equipment and trained personnel, making it difficult to implement in decentralized settings. Current point-of-care (POC) plasma separation methods are limited to microliter blood volumes, which are insufficient for high-sensitivity clinical applications; these tools also require manual operation and yield limited plasma volumes. Here, we present PlasmaLIFT (Large-volume Immunodepletion and Filtration Tool), an automated and compact device that uniquely combines two plasma separation strategies-immunomagnetic red blood cell depletion that enables downstream filtration without clogging, and a dual membrane size-exclusion filtration recently developed that removes remaining cells-to enable rapid, efficient plasma separation from 5 mL of whole blood within 10 minutes. PlasmaLIFT removes over 99.9% of cellular components without needing significant dilution or causing hemolysis, achieves a high plasma recovery efficiency of 80% at physiological hematocrit levels, and produces plasma containing clinically relevant biomarkers-demonstrated here for proteins, metabolites, lipids, nucleic acids, and viruses-at levels comparable to those obtained with centrifugation. This scalable, automated, centrifuge-free approach facilitates high-volume plasma separation in decentralized settings, potentially expanding access to sensitive blood-based diagnostic testing; future work to reduce the cost of magnetic beads at scale will expand access even further to low-resource settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.